Merja Voutilainen

RSS feed of this list

  1. E-pub ahead of print
  2. Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra

    Mätlik, K., Vihinen, A. H., Bienemann, A., Palgi, J., Voutilainen, M. H., Booms, S., Lindahl, M. S., Jokitalo, E. S., Saarma, M., Huttunen, H. J., Airavaara, M. T. & Arumäe, U. 20 Feb 2017 In : eNeuro. 4, 1, 15 p., e0128-16.2017

    Research output: Contribution to journalArticle

  3. Development and plasticity of meningeal lymphatic vessels

    Antila, S., Karaman, S., Nurmi, H., Airavaara, M., Voutilainen, M. H., Mathivet, T., Chilov, D., Li, Z., Koppinen, T., Park, J-H., Fang, S., Aspelund, A., Saarma, M., Eichmann, A., Thomas, J-L. & Alitalo, K. Dec 2017 In : Journal of Experimental Medicine. 214, 12, p. 3645-3667 23 p.

    Research output: Contribution to journalArticle

  4. Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat

    Penttinen, A-M., Suleymanova, I., Albert, K., Anttila, J., Voutilainen, M. & Airavaara, M. Apr 2016 In : Journal of Neuroscience Research. 94, 4, p. 318-328 11 p.

    Research output: Contribution to journalArticle

  5. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease

    Voutilainen, M. H., Arumäe, U., Airavaara, M. & Saarma, M. 21 Dec 2015 In : FEBS Letters. 589, 24, p. 3739-3748 10 p.

    Research output: Contribution to journalReview Article

  6. Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease

    Bäck, S., Peränen, J., Galli, E., Pulkkila, P., Lonka-Nevalaita, L., Tamminen, T., Voutilainen, M. H., Raasmaja, A., Saarma, M., Männistö, P. T. & Tuominen, R. K. Mar 2013 In : Brain and Behavior. 3, 2, p. 75-88 14 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next